Wei-Wu He
Insider Reports History
- Location
- Rockville, MD
- Signature
- /s/ Wei-Wu He
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Wei-Wu He:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CASI Pharmaceuticals, Inc. | Director, 10%+ Owner | Ordinary Share | 1,910,550 | $458,532 | $0.2400 | 18 Mar 2026 | Direct |
| CASI Pharmaceuticals, Inc. | Director, 10%+ Owner | Ordinary Share | 637,644 | $153,034 | $0.2400 | 18 Mar 2026 | Indirect |
| CASI Pharmaceuticals, Inc. | Chairman and CEO, Director, 10%+ Owner | Common Stock | 644,553 | 15 Jun 2022 | Direct | ||
| CASI Pharmaceuticals, Inc. | Chairman and CEO, Director, 10%+ Owner | Common Stock | 44,107 | 13 Jun 2022 | Indirect |
Insider Reports Filed by Wei-Wu He
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CASIF | CASI Pharmaceuticals, Inc. | 18 Mar 2026 | 0 | $0 | 3 | Director, 10%+ Owner | 18 Mar 2026, 19:06 |
| /report/000110465922072392-he-wei-wu-2022-06-13 | CASI Pharmaceuticals, Inc. | 13 Jun 2022 | 3 | +$272,506 | 4 | Chairman and CEO, Director, 10%+ Owner | 17 Jun 2022, 16:14 |
| /report/000110465921141867-he-wei-wu-2021-11-17 | CASI Pharmaceuticals, Inc. | 17 Nov 2021 | 2 | +$394,000 | 4 | Chairman and CEO, Director | 19 Nov 2021, 15:10 |
| /report/000110465921108182-he-wei-wu-2021-08-18 | CASI Pharmaceuticals, Inc. | 18 Aug 2021 | 2 | +$613,800 | 4 | Chairman and CEO, Director | 20 Aug 2021, 16:27 |
| /report/000110465921081983-he-wei-wu-2021-06-15 | CASI Pharmaceuticals, Inc. | 15 Jun 2021 | 1 | $0 | 4 | Chairman and CEO, Director, 10%+ Owner | 16 Jun 2021, 16:01 |